Answers are grounded in this paper and cite their sources.
In the CALCIPHYX trial, we investigated hexasodium fytate, an inhibitor of vascular calcification, for the treatment of calcific uraemic arteriolopathy (calciphylaxis), a rare condition characterised by painful, non-healing skin lesions.
No takes yet. Share an insight, caveat, or question.
Sinha et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: